Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?

被引：21

作者：

Iguchi, Haruo ^{[1
]}

机构：

[1] Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime 7910280, Japan

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2015年 / 21卷 / 43期

关键词：

Disseminated carcinomatosis of the bone marrow; Gastric cancer; Patogenesis; Diagnosis; Treatment; DISSEMINATED INTRAVASCULAR COAGULATION; BREAST-CANCER; PHASE-III; METASTASIS; CELLS; EXPRESSION; CISPLATIN; FEATURES; GROWTH;

D O I：

10.3748/wjg.v21.i43.12249

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Disseminated carcinomatosis of the bone marrow is characterized by widespread bone metastasis (bone marrow infiltration) from solid tumors with hematological disorders coexisted. This disease is frequently complicated with gastric cancer among solid tumors although its incidence is very rare. In recent years, technological innovations in diagnosis and treatment for cancer have remarkably improved, which made survival rates of various cancers prolonged. Prognosis of disseminated carcinomatosis of the bone marrow associated with gastric cancer, however, is still poor (less than a year), possibly because this disease has not been given attention due to low incidence. In this review, I summarize the results obtained for the past, and propose ways to improve the prognosis of this disease.

引用

页码：12249 / 12260

页数：12

共 56 条

[1] Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates [J].

Aft, Rebecca ;

Perez, Jose-Ricardo ;

Raje, Noopur ;

Hirsh, Vera ;

Saad, Fred .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (02) :233-248

[2]

[Anonymous], 1998, GASTRIC CANCER, V1, P10

[3]

Bang YJ, 2010, LANCET, V376, P1302

[4]

BERTINO JR, 1977, CANCER RES, V37, P327

[5] Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study [J].

Boku, Narikazu ;

Yamamoto, Seiichiro ;

Fukuda, Haruhiko ;

Shirao, Kuniaki ;

Doi, Toshihiko ;

Sawaki, Akira ;

Koizumi, Wasaburo ;

Saito, Hiroshi ;

Yamaguchi, Kensei ;

Takiuchi, Hiroya ;

Nasu, Junichiro ;

Ohtsu, Atsushi .

LANCET ONCOLOGY, 2009, 10 (11) :1063-1069

[6] Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow [J].

Cabioglu, N ;

Sahin, A ;

Doucet, M ;

Yavuz, E ;

Igci, A ;

Yildirim, EO ;

Aktas, E ;

Bilgic, S ;

Kiran, B ;

Deniz, G ;

Price, JE .

CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (01) :39-46

[7] PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling [J].

Conley-LaComb, M. Katie ;

Saliganan, Allen ;

Kandagatla, Pridvi ;

Chen, Yong Q. ;

Cher, Michael L. ;

Chinni, Sreenivasa R. .

MOLECULAR CANCER, 2013, 12

[8] Integrin adhesion receptors in tumor metastasis [J].

Felding-Habermann, B .

CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (03) :203-213

[9] Effectiveness and Safe Use of Modified FOLFOX-6 for Metastatic Gastric Cancer with Signet Ring Cell Components Complicated by Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis [J].

Ferrand, Francois-Regis ;

Gontier, Eric ;

Guymar, Sophie ;

Fagot, Thierry ;

Ceccaldi, Bernard ;

Malfuson, Jean-Valere ;

de Revel, Thierry .

ONKOLOGIE, 2012, 35 (03) :118-120

[10]

Fujishima Yoshimi, 2009, Gan To Kagaku Ryoho, V36, P2653

← 1 2 3 4 5 6 →